Meeting
2018 ASCO Annual Meeting
Adherence to hormonal therapy among commercially insured breast cancer patients.
Authors
Hui Zhao
Health Services Research Department, The University of Texas MD Anderson Cancer Center, Houston, TX
Hui Zhao , Xiudong Lei , Mariana Chavez-MacGregor , Weiguo He , Jiangong Niu , Sharon Hermes Giordano
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 36, 2018 (suppl; abstr 532)
DOI
10.1200/JCO.2018.36.15_suppl.532
Abstract #
532
Poster Bd #
24
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Racial disparities in initiation of endocrine therapy for early-stage breast cancer.
First Author: Katherine Elizabeth Reeder-Hayes
Poster
2014 ASCO Annual Meeting
Medicare Part D low-income subsidy and disparities in breast cancer treatment.
First Author: Alana Biggers
Poster
2021 ASCO Annual Meeting
Associations between preexisting nociplastic pain and early discontinuation of aromatase inhibitor therapy in breast cancer.
First Author: Elizabeth Joyce
Poster
2015 ASCO Annual Meeting
Phase III study of Palbociclib in combination with Exemestane vs. Capecitabine, in Hormonal Receptor (HR) positive/HER2 negative Metastatic Breast Cancer (MBC) patients with Resistance to non-steroidal Aromatase inhibitors (NSAI): PEARL study (GEICAM/2013-02_CECOG/BC.1.3.006)
First Author: Miguel Martin